Correlation Between CanSino Biologics and Evotec SE

Can any of the company-specific risk be diversified away by investing in both CanSino Biologics and Evotec SE at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CanSino Biologics and Evotec SE into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CanSino Biologics and Evotec SE, you can compare the effects of market volatilities on CanSino Biologics and Evotec SE and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CanSino Biologics with a short position of Evotec SE. Check out your portfolio center. Please also check ongoing floating volatility patterns of CanSino Biologics and Evotec SE.

Diversification Opportunities for CanSino Biologics and Evotec SE

0.63

Correlation Coefficient

CanSino Biologics  Evotec SE

Poor diversification

The 3 months correlation between CanSino and Evotec is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding CanSino Biologics and Evotec SE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evotec SE and CanSino Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CanSino Biologics are associated (or correlated) with Evotec SE. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evotec SE has no effect on the direction of CanSino Biologics i.e., CanSino Biologics and Evotec SE go up and down completely randomly.

Pair Corralation between CanSino Biologics and Evotec SE

Assuming the 90 days trading horizon CanSino Biologics is expected to generate 2.67 times less return on investment than Evotec SE. But when comparing it to its historical volatility, CanSino Biologics is 1.41 times less risky than Evotec SE. It trades about 0.08 of its potential returns per unit of risk. Evotec SE is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest  527.00  in Evotec SE on October 15, 2024 and sell it today you would earn a total of  315.00  from holding Evotec SE or generate 59.77% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

CanSino Biologics  vs.  Evotec SE

CanSino Biologics

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in CanSino Biologics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, CanSino Biologics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Evotec SE

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Evotec SE are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Evotec SE unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with CanSino Biologics and Evotec SE

The main advantage of trading using opposite CanSino Biologics and Evotec SE positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CanSino Biologics position performs unexpectedly, Evotec SE can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evotec SE will offset losses from the drop in Evotec SE's long position.

The idea behind CanSino Biologics and Evotec SE pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.